Insider Transactions in Q1 2025 at Xilio Therapeutics, Inc. (XLO)
Insider Transaction List (Q1 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 02
2025
|
Kevin M. Brennan SVP, FINANCE AND ACCOUNTING |
SELL
Open market or private sale
|
Direct |
1,803
-36.06%
|
$0
$0.98 P/Share
|
|
Jan 02
2025
|
Christopher James Frankenfield Chief Financial Officer |
SELL
Open market or private sale
|
Direct |
6,954
-35.89%
|
$0
$0.98 P/Share
|
|
Jan 01
2025
|
Rene Russo PRESIDENT AND CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
44,250
+15.3%
|
-
|
|
Jan 01
2025
|
Kevin M. Brennan SVP, FINANCE AND ACCOUNTING |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
-
|
|
Jan 01
2025
|
Christopher James Frankenfield Chief Financial Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
19,375
+50.0%
|
-
|
|
Jan 01
2025
|
Katarina Luptakova CHIEF MEDICAL OFFICER |
BUY
Exercise of conversion of derivative security
|
Direct |
16,625
+50.0%
|
-
|